Comment on ‘Prospective predictive performance comparison between clinical gestalt and validated COVID-19 mortality scores’
10.1136/jim-2021-002243
January 5, 2022
COVID-19
Tocilizumab in patients hospitalized with COVID-19 pneumonia: systematic review and meta-analysis of randomized controlled trials
10.1136/jim-2021-002001
September 24, 2021
Variation in clinical characteristics, outcomes, and mortality of hospitalized patients with COVID-19 during the second wave of the pandemic: a single-center experience
10.1136/jim-2021-001876
September 13, 2021
Predictors of misperceptions, risk perceptions, and personal risk perceptions about COVID-19 by country, education and income
10.1136/jim-2021-001835
August 11, 2021
Complications of nasal SARS-CoV-2 testing: a review
10.1136/jim-2021-001962
August 4, 2021
Behaviors, symptoms, and outcomes of North American patients with autoimmune hepatitis during the COVID-19 pandemic
10.1136/jim-2021-001871
July 27, 2021
Another new application of heparin in COVID-19: more than anticoagulation and antiviral
10.1136/jim-2021-001951
June 10, 2021
Fauci effect? When the heart is in the right place, but reality is not
10.1136/jim-2021-001949
June 1, 2021
Correlation of rate of serum albumin decline with other acute phase reactants and effect of current treatment options on serum albumin level in COVID-19
10.1136/jim-2021-001881
May 28, 2021
Dynamic albumin values as clinical surrogate for COVID-19 therapeutics
10.1136/jim-2021-001895
May 28, 2021